文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

氢化可的松、维生素C与硫胺素治疗脓毒性休克的评估:一项随机对照试验(HYVITS试验)

EVALUATION OF HYDROCORTISONE, VITAMIN C, AND THIAMINE FOR THE TREATMENT OF SEPTIC SHOCK: A RANDOMIZED CONTROLLED TRIAL (THE HYVITS TRIAL).
PubMed 文献 · Shock · 2023-03-08
一句话结论在脓毒性休克成人患者中,氢化可的松、维生素C与硫胺素三联疗法未改善60天内住院死亡率(28.3% vs 35.8%,P=0.41)。

本研究为在卡塔尔4个重症监护病房开展的多中心、开放标签、双臂平行组随机对照试验,纳入需去甲肾上腺素≥0.1 μg/kg/min持续≥6小时的成人脓毒性休克患者,随机分为三联疗法组(氢化可的松、维生素C、硫胺素)或对照组。主要终点为60天内或出院时(以先发生者为准)的住院死亡率,两组相似(三联疗法28.3% vs 对照组35.8%,P=0.41)。幸存者血管加压药持续时间两组相似(50小时 vs 58小时,P=0.44),其他次要及安全性终点亦相似。研究因缺乏资金提前终止,结论认为三联疗法未改善预后。

要点

  • 在需去甲肾上腺素≥0.1 μg/kg/min持续≥6小时的脓毒性休克成人中,三联疗法组60天内住院死亡率28.3%,对照组35.8%,P=0.41。
  • 幸存者血管加压药持续时间三联疗法组50小时 vs 对照组58小时,P=0.44,无显著差异。
  • 随机化72小时SOFA评分变化、ICU住院时间、医院住院时间等次要终点两组相似。
  • 研究因缺乏资金提前终止,共纳入106例患者(每组53例),基线SOFA评分中位数10(四分位距8-12)。

适用人群与场景

  • 在卡塔尔4个重症监护病房收治的成人脓毒性休克患者,需去甲肾上腺素以≥0.1 μg/kg/min速率持续≥6小时。

研究设计与关键结果

  • 研究类型:多中心、开放标签、双臂平行组随机对照试验,在卡塔尔4个重症监护病房开展,共纳入106例患者(每组53例),因缺乏资金提前终止。
  • 主要终点:60天内或出院时(以先发生者为准)住院死亡率,三联疗法组28.3% vs 对照组35.8%,P=0.41。
  • 次要终点:幸存者血管加压药持续时间三联疗法组50小时 vs 对照组58小时,P=0.44;随机化72小时SOFA评分变化、ICU住院时间、医院住院时间两组相似;其他次要及安全性终点两组相似。
  • 基线SOFA评分中位数10(四分位距8-12)。

证据类型、等级与局限

  • 证据类型:随机对照试验(RCT)。
  • 局限:研究因缺乏资金提前终止;原文未报告其他局限性。

对床旁实践的改变

  • 作者认为,对于脓毒性休克危重患者,三联疗法未改善60天内住院死亡率,也未缩短血管加压药持续时间或改善72小时SOFA评分;原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Purpose: The aim of the study is to evaluate the effect of combined hydrocortisone, vitamin C, and thiamine (triple therapy) on the mortality of patients with septic shock. Methods : This multicenter, open-label, two-arm parallel-group, randomized controlled trial was conducted in four intensive care units in Qatar. Adult patients diagnosed with septic shock requiring norepinephrine at a rate of ≥0.1 μg/kg/min for ≥6 h were randomized to a triple therapy group or a control group. The primary outcome was in-hospital mortality at 60 days or at discharge, whichever occurred first. Secondary outcomes included time to death, change in Sequential Organ Failure Assessment (SOFA) score at 72 h of randomization, intensive care unit length of stay, hospital length of stay, and vasopressor duration. Results: A total of 106 patients (53 in each group) were enrolled in this study. The study was terminated early because of a lack of funding. The median baseline SOFA score was 10 (interquartile range, 8-12). The primary outcomes were similar between the two groups (triple therapy, 28.3% vs. control, 35.8%; P = 0.41). Vasopressor duration among the survivors was similar between the two groups (triple therapy, 50 h vs. control, 58 h; P = 0.44). Other secondary and safety endpoints were similar between the two groups. Conclusion: Triple therapy did not improve in-hospital mortality at 60 days in critically ill patients with septic shock or reduce the vasopressor duration or SOFA score at 72 h. Trial Registration:ClinicalTrials.gov identifier: NCT03380507. Registered on December 21, 2017.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Mohamed A, Abdelaty M, Saad MO, et al. EVALUATION OF HYDROCORTISONE, VITAMIN C, AND THIAMINE FOR THE TREATMENT OF SEPTIC SHOCK: A RANDOMIZED CONTROLLED TRIAL (THE HYVITS TRIAL). Shock. 2023. PMID: 36870070. doi:10.1097/SHK.0000000000002110

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。